MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

A

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

Search

Design Therapeutics Inc

Fechado

5.82 2.46

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.59

Máximo

5.93

Indicadores-chave

By Trading Economics

Rendimento

-1.4M

-19M

Margem de lucro

-2,321.599

Funcionários

57

EBITDA

-1.3M

-22M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

-12.89% downside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

159M

384M

Abertura anterior

3.36

Fecho anterior

5.82

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Design Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

20 de out. de 2025, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Takaichi's Policy Steps -- Market Talk

20 de out. de 2025, 23:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

20 de out. de 2025, 23:36 UTC

Conversa de Mercado

Gold Edges Higher on Likely Dip-Buying Interest -- Market Talk

20 de out. de 2025, 22:14 UTC

Conversa de Mercado

Zions Management Confident $50M Charge Was Isolated Event -- Market Talk

20 de out. de 2025, 22:00 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Berkshire May Have Left $50 Billion on Table. Apple Stock Hit a Record. -- Barrons.com

20 de out. de 2025, 21:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Kering Sells Beauty Business to L'Oréal. Everyone but This Company Wins. -- Barrons.com

20 de out. de 2025, 20:56 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Moved the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More -- Barrons.com

20 de out. de 2025, 20:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

20 de out. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

20 de out. de 2025, 20:38 UTC

Ganhos

Steel Dynamics: Encouraging Demand Drivers of Manufacturing Onshoring, Infrastructure Program Funding, Lower Interest Rates, Increasing Regionalization of Supply Chains in U.S. >STLD

20 de out. de 2025, 20:38 UTC

Ganhos

Steel Dynamics: Expect to Benefit From Stronger Demand Across Platforms, Including Aluminum Flat Rolled Products, as We Move Into 2026 >STLD

20 de out. de 2025, 20:38 UTC

Ganhos

Steel Dynamics: Some Order Hesitancy From Flat Rolled Steel Customers Due to Domestic Trade Actions >STLD

20 de out. de 2025, 20:36 UTC

Ganhos

Steel Dynamics: Continue to Observe Some Customer Inventory Overhang of Value-Added Flat Rolled Products That Were Imported Earlier This Yr >STLD

20 de out. de 2025, 20:36 UTC

Ganhos

Steel Dynamics: View U.S. Intl Trade Commission's Final Determinations on Coated Flat Rolled Steel as a Significant Positive Development >STLD

20 de out. de 2025, 20:36 UTC

Ganhos

Steel Dynamics: Discussions With Customers Reinforce the Increasing Importance of Low-Carbon, U.S.-Made Steel and Aluminum, Positioning Our Businesses for a Long-Term Competitive Advantage >STLD

20 de out. de 2025, 20:36 UTC

Ganhos

Steel Dynamics: Improving Market Conditions, Including Increased Trade Stability and Favorable Interest Rate Environment, Will Contribute to Strong Domestic Demand for Steel and Aluminum >STLD

20 de out. de 2025, 20:16 UTC

Conversa de Mercado

Canada Labor-Market Indicators Lean Dovish -- Market Talk

20 de out. de 2025, 20:05 UTC

Ganhos

GE Aerospace Earnings Are on Tap. After the Turnaround, Investors Wonder What's Next. -- Barrons.com

20 de out. de 2025, 19:39 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Industrials Post Positive Earnings. 3 Stocks Whose Charts Say 'Buy.' -- Barrons.com

20 de out. de 2025, 19:34 UTC

Conversa de Mercado

U.S. Natural Gas Futures Jump on Colder Weather Outlook -- Market Talk

20 de out. de 2025, 19:32 UTC

Conversa de Mercado

Oil Futures Extend Losses on Oversupply Concerns -- Market Talk

20 de out. de 2025, 19:00 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More -- Barrons.com

20 de out. de 2025, 18:29 UTC

Conversa de Mercado

Apple Sitting on Best Long-Term Product Roadmap in Years -- Market Talk

20 de out. de 2025, 18:11 UTC

Conversa de Mercado

Economic Vital Signs Missing in Bank of Canada Survey -- Market Talk

20 de out. de 2025, 18:04 UTC

Conversa de Mercado

Uncertainty Remains Top Concern Among Canada Firms -- Market Talk

20 de out. de 2025, 17:03 UTC

Conversa de Mercado

Weak Demand Signals Narrower Profit Margins For Canada Firms -- Market Talk

20 de out. de 2025, 17:01 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 de out. de 2025, 17:01 UTC

Conversa de Mercado

Bank of Canada Surveys Present Shaky Economic Outlook -- Market Talk

20 de out. de 2025, 16:43 UTC

Conversa de Mercado

Canada Public-Sector Workers Fret Most On Labor-Market Weakness -- Market Talk

20 de out. de 2025, 16:25 UTC

Conversa de Mercado

U.S. Natural Gas Extends Rebound on Weather Outlook -- Market Talk

Comparação entre Pares

Variação de preço

Design Therapeutics Inc Previsão

Preço-alvo

By TipRanks

-12.89% parte inferior

Previsão para 12 meses

Média 5 USD  -12.89%

Máximo 5 USD

Mínimo 5 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Design Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

3.26 / 3.63Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat